These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests. Barry AL, Jones RN, Thornsberry C. J Antimicrob Chemother; 1989 Mar; 23 Suppl C():17-30. PubMed ID: 2732139 [Abstract] [Full Text] [Related]
3. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. Maskell JP, Sefton AM, Williams JD. J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433 [Abstract] [Full Text] [Related]
4. In-vitro activity of a new penem FCE 22101. Hoban DJ. J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518 [Abstract] [Full Text] [Related]
5. In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101. Barry AL, Aldridge KE, Allen SD, Fuchs PC, Gerlach EH, Jones RN, Pfaller MA. Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):794-8. PubMed ID: 3145868 [Abstract] [Full Text] [Related]
6. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates. Murray PR, Niles AC. Diagn Microbiol Infect Dis; 1990 Dec; 13(1):57-61. PubMed ID: 2331851 [Abstract] [Full Text] [Related]
7. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics. Neu HC, Chin NX, Labthavikul P. J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100 [Abstract] [Full Text] [Related]
14. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria. Hu J, Zhang J, Wu S, Zhu D, Huang H, Chen Y, Yang Y, Zhang Y. Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712 [Abstract] [Full Text] [Related]
15. In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci. Adachi Y, Nakamura K, Kato Y, Hazumi N, Hashizume T, Nakagawa S. Antimicrob Agents Chemother; 1997 Oct; 41(10):2282-5. PubMed ID: 9333063 [Abstract] [Full Text] [Related]
17. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics. Wise R, Andrews JM, Danks G. Antimicrob Agents Chemother; 1983 Dec; 24(6):909-14. PubMed ID: 6607032 [Abstract] [Full Text] [Related]